Navigation Links
UCB and PDL BioPharma Resolve Patent Disputes
Date:2/8/2011

e to MTX or when continued treatment with MTX is inappropriate. UCB is also developing Cimzia® in other autoimmune disease indications. Cimzia is a registered trademark of UCB.

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8 000 people in about 40 countries, the company generated revenue of EUR 3.1 billion in 2009. UCB is listed on Euronext Brussels (symbol: UCB).

About PDL BioPharma

PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The Company receives royalties on sales of a number of humanized antibody products marketed by leading pharmaceutical and biotechnology companies today based on patents which expire in late 2014. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

Forward Looking Statements

This press release contains forward-looking statements. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from those, express or implied, in these forward-looking statements, including because UCB or PDL fail to timely fulfill their respective obligations under the settlement agreement. PDL and UCB expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in their respective expectations with regard thereto o
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inspiration Biopharmaceuticals Demonstrates Non-Inferiority of IB1001, Its Recombinant Factor IX for Hemophilia B
2. Laureate Pharma Changes Name to Laureate Biopharmaceutical Services, Inc.
3. PDL BioPharma Appoints Caroline Krumel as Vice President of Finance and Thanks Karen Wilson for her Contributions
4. Enox Biopharma, Inc. to Present at OneMedForum Emerging Company Finance Conference.
5. Genesis Biopharma to Present at 2011 Biotech Showcase Conference
6. PDL BioPharma to Present at the 29th Annual JP Morgan Healthcare Conference
7. Pharmaceutical Industry Labor-Management Association Applauds Senator Casey (D-PA) for Biopharmaceutical Job Creation Efforts
8. Sutro Biopharma Appoints Trevor Hallam, Ph.D., as Chief Scientific Officer
9. Data from Phase 2 Study of Alder Biopharmaceuticals Anti-IL-6 Antibody Therapeutic, ALD518, Demonstrate Reversal of Anemia in Patients with Advanced Non-Small Cell Lung Cancer
10. Inspiration Biopharmaceuticals Treats First Patient in Pivotal Study of OBI-1 for Acquired Hemophilia A
11. Sutro Biopharma Secures $36.5 Million in Series C Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014  Beamz Interactive, ... interactive music products, today announced that it has ... leading manufacturer and supplier of innovative prosthetic, orthotic ... As part of the agreement, RSL Steeper will ... solution specifically configured for use within UK residential ...
(Date:12/17/2014)...  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) ... (USPTO) has issued a key patent covering ImmunoCellular,s ... targeting six tumor antigens that are commonly expressed ... 8,871,211, which issued October 28, 2014, include methods ... cell composition comprising peptide epitopes of the six ...
(Date:12/17/2014)... MARLBOROUGH, Mass. , Dec. 17, 2014 /PRNewswire/ ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today announced completion of enrollment in ... results from the 3-month observations confirmed the 1-month ... year:  Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
Breaking Medicine Technology:Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... 2011 FDA Commissioner Margaret A. Hamburg, M.D., ... can be taken to drive biomedical innovation, while ... http://photos.prnewswire.com/prnh/20090824/FDALOGO) Titled "Driving Biomedical Innovation: Initiatives ... concerns about the sustainability of the medical product ...
... ConvaTec, a world-leading developer and marketer of innovative medical ... Ltd, a wholly-owned subsidiary of ConvaTec Holdings UK Ltd, has ... the home delivery of stoma and continence care products. ... of England, and as a well-respected company in the home ...
Cached Medicine Technology:FDA Commissioner Outlines Steps to Spur Biomedical Innovation, Improve Health of Americans 2ConvaTec Announces Acquisition of Farnhurst Medical 2
(Date:12/19/2014)... December 19, 2014 B. E. Smith, ... healthcare providers, has been retained to lead a national ... Medical Center in Estes Park, Colo. The top executive ... has recently placed more than 900 healthcare executives into ... a 25-bed, not-for-profit critical access hospital and level IV ...
(Date:12/19/2014)... Hands On Mobile Spa, has announced they ... On Wheels has been transformed into a utopia for the ... seems to disappear. The Virtual Tour showcases the beauty of ... corporate events and more. , The Virtual Tour shows viewers ... is actually an overhauled Winnebago. Marla Kaplan-Pelle, Director states " ...
(Date:12/19/2014)... Slone Partners , a national recruitment ... technology, and laboratory testing industries, has promoted Leslie ... The announcement comes after a year of expansion ... in Boston and several new additions to the ... client experience," said Adam Slone, Chief Executive Officer. ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 The ... ski club in Southern Vermont’s Deerfield Valley, announced today ... inspired by classic rock songs. , Three time ... with a private concert followed by a trail naming ... new trail names include: “I’m Alright” the theme song ...
(Date:12/19/2014)... By Amy Norton ... -- Children born to moms who were exposed to high ... increased risk of developing autism, a U.S. study suggests. ... birth between 1990 and 2002, those exposed to the most ... a baby who later developed autism. And exposure during the ...
Breaking Medicine News(10 mins):Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 2Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 3Health News:Slone Partners Promotes Leslie Loveless to Chief Operating Officer 2Health News:The Hermitage Club Officially Names Four Ski Trails after Iconic Rock Songs by Grammy Award Winner Kenny Loggins 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3
... Dynamics Company,Ltd.) (TSX: IDL), the global leader in ... that it has been awarded a contract by,the ... India for,five X-Series 1600 DR systems with X4C ... placed for DR equipment by the government in,India ...
... not be the major cause of hyperactivity in children. Genetics, ... just as important. , A review ... actually affected by what they eat. A combination of food, ... with no single factor to blame. , Foods which ...
... Transplant,Foundation (MTF) will provide military hospitals with special ... for injured servicemen and,women., Military hospitals and ... for cartilage transplantation and meniscus grafts used for,joint ... tissue are in high,demand for U.S. servicemen and ...
... has awarded one of 14 Clinical and Translational Science ... Boston University Medical (BUMC) and Charles River Campuses and ... CTSAs awarded in 2007, and 12 awarded in 2006, ... a national consortium of select centers that will transform ...
... H. Antman, MD, provost of Boston University Medical Campus ... be honored with the Distinguished Service Award for Scientific ... at their annual meeting in Chicago this weekend. Antman, ... cancer, is widely recognized for her development of a ...
... a Useful Tool in Detection, as Sensitive as MRI ... Invasive Cancers and Perhaps More So for DCIS, NEWPORT ... June issue of Radiology, researchers at The George Washington,University Medical ... is highly sensitive in detecting the,presence of cancer. The researchers ...
Cached Medicine News:Health News:IDC awarded India's largest state government contract for digital radiography systems 2Health News:IDC awarded India's largest state government contract for digital radiography systems 3Health News:Children's diet not the main cause of ADHD 2Health News:BUMC, BMC receives Clinical and Translational Science Award from NIH 2Health News:BUMC provost, BUSM dean, to be honored at world's largest meeting of oncology professionals 2Health News:Breast-Specific Gamma Imaging (BSGI) Found to Be Highly Sensitive for Early Stage Breast Cancer 2
Consensus Knee implants are designed to provide both joint and implant stability and allow near normal kinematics. The components are anatomic with porous and nonporous options. Six femoral/tibial an...
Alpina Uni Knee Prosthesis is designed to meet anatomical requirements and particularly the differences between medial and lateral femoral condyles....
The Genesis II total knee system defines the state of knee implants....
... inserts have radiused A/P and M/L ... maximizing conformity of the tibial insert ... femoral component. The resulting rotary arc ... and accommodates the knee's natural screw-home ...
Medicine Products: